Table 1. Patient characteristics and RCC engraftment in mice.

Patients	Age/ gender	Primary RCC (PRCC)			Corresponding metastasis (CM)
		TNM (25)	Fürhman grade	Engraftment of PRCC	Metastasis	Metastasis biopsy	Time of Metastasis
1	49/M	pT1bN0M0	2	No	No
2	69/F	pT3bN0M0	3	No	No
3	46/M	pT3bN0M0	3	No	No
4	57/M	pT1bN0M0	3	No	No
5	62/M	pT1bN0M0	3	No	No
6	72/M	pT1aNxM0	3	No	No
7	58/M	pT1bNxM0	2	No	No
8	57/M	pT1aNxM0	3	No	No
9	66/M	pT1aN0M0	3	No	No
10	72/M	pT1aNxM0	2	No	No
11	59/M	pT1aNxM0	3	No	No
12	68/M	pT3aNxM0	2	No	No
13	83/F	pT1bN0M0	3	No	No
14	58/M	pT1bN0M0	2	No	No
15	67/M	pT1aNxM0	3	No	No
16	80/F	pT2N0M0	2	No	No
17	70/F	pT3aNxM0	2	No	Yes	No	During the evolution
18	58/M	pT3aN0M0	4	No	Yes	No	During the evolution
19	67/M	pT4N1M0	4	No	Yes	No	During the evolution
20	59/F	pT3aNxM0	3	No	Yes	No	During the evolution
21	76/M	pT1bN0M1	3	No	Yes	No	At diagnosis
22	81/F	pT3aNxM1	3	No	Yes	No	At diagnosis
23	45/M	pT3N0M1	2	No	Yes	No	At diagnosis
24	71/M	pT3bNxM1	3	No	Yes	No	At diagnosis
25	54/M	pT3bNxM1	3	No	Yes	Yes	At diagnosis
26	62/M	pT3bN0M1	3	No	Yes	Yes	At diagnosis
27	55/M	pT2N0M1	3	No	Yes	Yes	At diagnosis
28	63/M	pT3aNxM1	3	No	Yes	Yes	At diagnosis
29	68/M	pT4NxM1	4	Yes	Yes	No	At diagnosis
30	62/F	pT3aN1M1	3	Yes	Yes	No	At diagnosis
31	51/F	pT3bN1M1	3	Yes	Yes	No	At diagnosis
32	52/M	pT3bN1M1	4	Yes	Yes	No	At diagnosis
33	63/M	pT1aN1M1	4	Yes	Yes	Yes	At diagnosis
34	57/M	pT3bNxM1	4	Yes	Yes	Yes	At diagnosis
35	67/F	pT3bN1M1	4	Yes	Yes	Yes	At diagnosis
36	74/M	pT1aNxM0	3	Yes	Yes	Yes	During the evolution